Akari Therapeutics plc (AKTX)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20268 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Akari Therapeutics plc’s names, not what it holds today.
20 published
6 published
3 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jun 19, 2025 | 2025/0195612 | Coversin for use in the treatment of rheumatic diseases | Pharmaceuticals | Volution Immuno Pharmaceuticals SA |
| Jan 11, 2024 | 2024/0009270 | COVERSIN FOR THE TREATMENT OF AUTOIMMUNE BLISTERING DISEASES | Pharmaceuticals | Volution Immuno Pharmaceuticals SA |
| Jan 5, 2023 | 2023/0002456 | Coversin Variants Lacking C5 Binding | Biotechnology | Volution Immuno Pharmaceuticals SA |
| Nov 24, 2022 | 2022/0370556 | Method of Treatment | Pharmaceuticals | Volution Immuno Pharmaceuticals SA |
| Nov 17, 2022 | 2022/0363726 | Method of Inhibiting C5 Cleavage | Pharmaceuticals | Volution Immuno Pharmaceuticals SA |
| Aug 11, 2022 | 2022/0249608 | Method of Treating Peripheral Nerve Disorders | Pharmaceuticals | Volution Immuno Pharmaceuticals SA |
| Jul 7, 2022 | 2022/0211810 | Method of Treatment | Pharmaceuticals | Volution Immuno Pharmaceuticals SA |
| Feb 17, 2022 | 2022/0047673 | Coversin for Use in the Treatment of Rheumatic Diseases | Pharmaceuticals | Volution Immuno Pharmaceuticals SA |
| Sep 16, 2021 | 2021/0283221 | Ornithodoros Moubata Complement Inhibitor for Use in the treatment of Complement-Mediated Diseases in Patients with C5 Polymorphism | Pharmaceuticals | Volution Immuno Pharmaceuticals SA |
| Aug 12, 2021 | 2021/0244792 | Method of Treating Respiratory Disorders | Pharmaceuticals | Volution Immuno Pharmaceuticals SA |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.